Diagnosis & ScreeningResearch
Emerging Biomarker Tests May Complement Autism Identification, With Key Limitations
From eye-tracking to stool analysis, research explores objective tools to identify autism traits earlier — though experts emphasize these may apply to specific subgroups and require more validation.
Expanding Options for Identification
Traditional autism identification has relied on behavioral observations, typically possible after age 2-3. Emerging research explores whether biological markers could provide additional insights. A 2024 study in Nature Communications examining gut microbiome metabolites found associations with certain autism subgroups, though the researchers note these may relate to co-occurring gastrointestinal patterns rather than autism itself. One experimental stool analysis tool received FDA Breakthrough Device designation — a status that accelerates regulatory review but does not confirm clinical effectiveness, as explained by the FDA.
Eye-tracking research also shows potential. A May 2024 JAMA Network Open study involving 350 infants found that specialized 20-minute eye-tracking protocols could help flag developmental differences. However, the authors caution this requires specific equipment and training not typically available in pediatric offices.
A May 2024 JAMA Network Open study involving 350 infants found that specialized 20-minute eye-tracking protocols could help flag developmental differences.
Digital Analysis Approaches
Some researchers are exploring whether technology can help analyze behavioral patterns. A 2023 Nature Medicine study trained algorithms on videos of children's play sessions in clinical settings, finding potential to identify certain developmental differences. This 'digital phenotyping' approach remains experimental and has only been tested in controlled research environments.
These diverse approaches share a goal of expanding identification options beyond current methods. Earlier recognition of developmental differences could help families access supportive services, though as a 2024 Frontiers in Psychiatry review notes, biomarker research must balance scientific potential with ethical considerations. Current AAP guidelines continue to recommend behavioral screening tools like the M-CHAT for routine developmental monitoring.
Sources
- 01Elevated microbially-derived metabolites in autism: a possible diagnostic screening test for a distinct ASD phenotype
- 02Eye-Tracking Biomarkers and Autism Diagnosis in Primary Care
- 03Early detection of autism using digital behavioral phenotyping - Nature
- 04Mapping the structure of biomarkers in autism spectrum disorder
Common questions
Behind the brief
Adversarial editorial review
Open thread